ONE-TWENTY TWO: Trading Financial Markets
Exploring the poetry in financial markets for students of money and economy since the year 2000.
I took immediate notice when Axovant Sciences (AXON) went public back in late 2015. The promise of a treatment for Alzheimer’s was a huge opportunity, and I immediately had thoughts of my grandfather who struggled with the disease for years before he passed away with a heart attack. Yet, AXON had no revenues and no … Read more
AT40 = 63.6% of stocks are trading above their respective 40-day moving averages (DMAs) AT200 = 54.9% of stocks are trading above their respective 200DMAs VIX = 9.6 Short-term Trading Call: cautiously bullish Commentary The stock market stubbornly held onto its bullish positioning despite the tumble of one of its biggest stalwarts: Apple (AAPL). AAPL … Read more
AT40 = 60.4% of stocks are trading above their respective 40-day moving averages (DMAs) AT200 = 53.2% of stocks are trading above their respective 200DMAs VIX = 10.2 Short-term Trading Call: cautiously bullish Commentary North Korea launched another ballistic missile over Japan, this one with enough range to hit Guam. The general market response was … Read more
AT40 = 53.0% of stocks are trading above their respective 40-day moving averages (DMAs) AT200 = 51.1% of stocks are trading above their respective 200DMAs VIX = 10.7 (down 11.5%) Short-term Trading Call: neutral (see below for caveats) Commentary I had no idea that the previous tensions in the stock market fully priced in the … Read more
Teva Pharmaceuticals (TEVA) lost 24% last Thursday after reporting disappointing earnings. From the Seeking Alpha transcript of the conference call: “All of us at Teva understand the frustration and disappointment our shareholders are feeling… In our U.S. Generics business, we experienced accelerated price erosion and decreased volume, mainly due to customer consolidation, greater competition as … Read more